1590TiP - Safety, tolerability and activity of autologous T-cells with enhanced T-cell receptors specific to NY ESO 1/LAGE 1a (GSK3377794) alone, or in combination with pembrolizumab, in advanced non-small cell lung cancer: A phase Ib/IIa randomised pilot study

Autor:	Reckamp, K.L. 1, Akerley, W. 2, Calvo, E. 3, Clarke, J. 4, Edelman, M.J. 5, He, K. 6, Moreno, V. 7, Neal, J.W. 8, Owonikoko, T.K. 9, Patel, J.D. 10, Patel, S.P. 11, Riess, J.W. 12, Sacher, A.G. 13, Turcotte, S. 14, Villaruz, L.C. 15, Zauderer, M.G. 16, Farsaci, B. 17, Skoura, N. 18, Chisamore, M. 19, Johnson, M.L. 20
Zdroj:	In Annals of Oncology October 2019 30 Supplement 5:v657-v658
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu